Skip to main content


Welcome on our new webpage!

The Multiplicom website has moved! Since we are part of Agilent Technologies, we have found a place for our Next-Generation Sequencing solutions (NGS) on the website. Don’t worry, we are still guiding you towards better results every step of the way, together with Agilent. You can find all your trusted links on the following new Agilent pages:

Testkits & Reporters
Human Offerings
MASTR reporter
Onco Offerings
Clarigo reporter
Prenatal Offerings
Continuous Support
Proof of Principle
Workshops & Training
Expert Service
Enabling Services
Customer Downloads
Frequently Asked Questions
Guiding you towards better results. Every step of the way.

We have been a strong and reliable player in molecular diagnostics for many years. All our products and solutions incorporate the latest medical findings on human genetics, oncology and prenatal testing and are developed and manufactured in compliance with the most stringent international quality standards.

We provide your laboratory with a broad range of molecular NGS solutions, which guide your laboratory towards the more reliable results. Our ready-to-use kits analyze the genes that matter in a simple, efficient and reliable manner. Our Reporter software ensures correct analysis and enables quality control, from sample to final result. Our Facility lab and Expert customer support team help you to set up our tests and secure your results in every step of the way. Click here for our product range.

MASTR Technology

Recent advances in various areas of clinical medicine, diagnostics and genetic testing have created a significant opportunity for the development of high value genetic tests to enable the practice of personalized medicine. The availability of affordable Next-Generation Sequencing systems provides the foundation on which PCR based technologies can be applied to address a wide range of unmet needs.

Click here for more information on our NGS Technology.

Quality standards for Next-Generation Sequencing solutions

Our MASTR technology has been developed and proven to obtain a high level of reliability. We aim to register our major products under the CE-IVD directives and maintain an ISO13485 quality standard. Click here for more information on our quality standards


SureMASTR BRCA Screen Newsitem

Agilent Technologies is proud to introduce, SureMASTR BRCA Screen, a new member of the amplicon-based BRCA solutions. SureMASTR BRCA Screen, in combination with the MASTR Reporter data analysis software, is a molecular research solution for the detection of variants in BRCA1, BRCA2, CHEK2, and PALB2. Read More

MR Speed newsitem

Agilent is pleased to announce that SureMASTR TP53 and ADH assays are now complemented with Agilent’s data analysis software MASTR Reporter. MASTR Reporter is tailored to SureMASTR assays and allows you, on top of variant analysis, to monitor and trace the quality of your results and manage the entire workflow of your laboratory. Read More

SureMASTR: Rebranding and removal of GeneScan reagents

Agilent Technologies is rebranding the MASTR assays! As of the 2nd of November, you will see that some of your familiar MASTR solutions will be rebranded to a new name: SureMASTR. Furthermore, the drMID kits (For Research Use Only. Not for use in diagnostic procedures) will be reconfigured. Read More

View all news updates


18-21 June 2019

Clarigo workshop June

8-11 October 2019

Clarigo workshop October

6-8 November 2019

SureMASTR Workshop November

7-10 January 2020

Clarigo workshop January

12-14 February 2020

SureMASTR Workshop February

31 March- 3 April 2020

Clarigo workshop March

13-15 May 2020

SureMASTR Workshop May

23-26 June 2020

Clarigo workshop June

View all events

Contact us

If you have any other questions, do not hesitate to contact us:


Europe & other countries: